TITLE

On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts

AUTHOR(S)
Sara Iachettini; Stevens, Malcolm F. G.; Frigerio, Mark; Hummersone, Marc G.; Hutchinson, Ian; Garner, Thomas P.; Searle, Mark S.; Wilson, David W.; Manoj Munde; Rupesh Nanjunda; D'Angelo, Carmen; Zizza, Pasquale; Rizzo, Angela; Cingolani, Chiara; De Cicco, Federica; Porru, Manuela; D'Incalci, Maurizio; Leonetti, Carlo; Biroccio, Annamaria; Salvati, Erica
PUB. DATE
October 2013
SOURCE
Journal of Experimental & Clinical Cancer Research (17569966);2013, Vol. 32 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Quadruplexes DNA are present in telomeric DNA as well as in several cancer-related gene promoters and hence affect gene expression and subsequent biological processes. The conformations of G4 provide selective recognition sites for small molecules and thus these structures have become important drug-design targets for cancer treatment. The DNA G-quadruplex binding pentacyclic acridinium salt RHPS4 (1) has many pharmacological attributes of an ideal telomere-targeting agent but has undesirable off-target liabilities. Notably a cardiovascular effect was evident in a guinea pig model,manifested by a marked and sustained increase in QTcB interval. In accordance with this,significant interaction with the human recombinant β2 adrenergic receptor,and M1,M2 and M3 muscarinic receptors was observed,together with a high inhibition of the hERG tail current tested in a patch clamp assay. Two related pentacyclic structures,the acetylamines (2) and (3),both show a modest interaction with β2 adrenergic receptor,and do not significatively inhibit the hERG tail current while demonstrating potent telomere on-target properties comparing closely with 1. Of the two isomers,the 2-acetyl-aminopentacycle (2) more closely mimics the overall biological profile of 1 and this information will be used to guide further synthetic efforts to identify novel variants of this chemotype,to maximize on-target and minimize off-target activities. Consequently,the improvement of toxicological profile of these compounds could therefore lead to the obtainment of suitable molecules for clinical development offering new pharmacological strategies in cancer treatment.
ACCESSION #
91261764

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics